HAVCR2 and adult T-cell leukemia/lymphoma: Additionally, Tim‐3 on ATLL cells and GAL9 on macrophages deactivates T cells and boosts ATLL growth,12 and patients with Tim‐3‐positive ATLL respond poorly to chemotherapy.